As a common tumor suppressor gene, phosphatase and tensin homolog (PTEN) inhibits the proliferation of cancer cells by down-regulating the PI3K/AKT/mTOR pathway [6,7], and is implicated in the development and progression of tumors, such as hepatocellular carcinoma [8], gastric cancer [9], prostate cancer [10], osteosarcoma [11], nasopharyngeal carcinoma [12], and BC. This evidence concerns the gene PTEN and prostate carcinoma.